VEGFA and cancer: This molecule works in cohort with other key mediators of angiogenesis, such as VEGF, TGFα, TGFβ, FGF, matrix metalloproteinases, interlukin-1 (IL-1), and TNFα; future studies would therefore be recommended to investigate the effects of combined treatments of cells with the drugs on the expressions of these angiogenic molecules in cancer therapy.